Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.

Item

http://www.wikidata.org/entity/Q41821207

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.

@en

type

Item

label

Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.

@en

prefLabel

Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.

@en

P1476

Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.

@en

P2093

Angela Raffaella Losito

http://www.w3.org/2001/XMLSchema#string

Barbara Fiori

http://www.w3.org/2001/XMLSchema#string

Elvira Liberto

http://www.w3.org/2001/XMLSchema#string

Eugenia Di Meco

http://www.w3.org/2001/XMLSchema#string

Giovanni Fadda

http://www.w3.org/2001/XMLSchema#string

Lara Campana

http://www.w3.org/2001/XMLSchema#string

Mario Tumbarello

http://www.w3.org/2001/XMLSchema#string

Teresa Spanu

http://www.w3.org/2001/XMLSchema#string

Tiziana D'Inzeo

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.

Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.

Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs

Characterization of a new extended-spectrum beta-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey.

Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.

P304

3224-3231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.05966-11

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Cauda

Enrico Maria Trecarichi

A Ruggeri

P577

2012-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22450979

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

3370815

http://www.w3.org/2001/XMLSchema#string